Diagnostic and Therapeutic Difficulties in Diffuse Large B-cell Lymphoma Arising From HHV8 Positive Castleman Disease

Edit Payer, Zsofia Miltenyi, Zsofia Simon, Ferenc Magyari, Sandor Barna, Gabor Mehes, Arpad Illes


Diffuse large B-cell lymphoma arising from multicentric Castleman disease is an aggressive disorder with short survival. In 2001 our 46-year old patient presented cervical lymphadenopathy. The third bioptic sample proved HHV8 positive Castleman disease in 2002. Chemoterapy (steroid, cyclophosphamide, CVP, interferon-alpha, thalidomide) and radiotherapy was given with themporary success. In 2009 compression of the respiratory tract needed mantle irradiation, and rapid progression developed, inguinal biopsy revealed DLBCL. R-CHOP was started, but the interim PET/CT showed no respons, thus therapy was changed to R-DHAP, autologous stem cell transplantation was planned. The stem cell collection was made after 2 cycles of chemotherapy. However, further progression could be detected which seemed to be chemoresistant (R-IGEV, R-ICE). Palliative irradiation was performed but serious myelosuppression was developed which led to febrile neutropenia with pneumonia and sepsis. Despite of targeted antibiotic treatment the infection caused our patient's death six months after the diagnosis of DLBCL. We would like to highlite the importance of the repeated biopsies if the behavior of a disease has changed and the rare disorders needed personalised treatment.



Castleman disease; Diffuse large B-cell lymphoma; 18FDG-PET/CT

Full Text: HTML PDF

Browse  Journals  


Journal of Clinical Medicine Research

Journal of Endocrinology and Metabolism

Journal of Clinical Gynecology and Obstetrics

World Journal of Oncology

Gastroenterology Research

Journal of Hematology

Journal of Medical Cases

Journal of Current Surgery

Clinical Infection and Immunity

Cardiology Research

World Journal of Nephrology and Urology

Cellular and Molecular Medicine Research

Journal of Neurology Research

International Journal of Clinical Pediatrics






Journal of Hematology, bimonthly, ISSN 1927-1212 (print), 1927-1220 (online), published by Elmer Press Inc.                            
The content of this site is intended for health care professionals.
This is an open-access journal distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License, which permits unrestricted
non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
Creative Commons Attribution license (Attribution-NonCommercial 4.0 International CC BY-NC 4.0)

This journal follows the International Committee of Medical Journal Editors (ICMJE) recommendations for manuscripts submitted to biomedical journals,
the Committee on Publication Ethics (COPE) guidelines, and the Principles of Transparency and Best Practice in Scholarly Publishing.

website: www.thejh.org    editorial contact: editor@thejh.org
Address: 9225 Leslie Street, Suite 201, Richmond Hill, Ontario, L4B 3H6, Canada

© Elmer Press Inc. All Rights Reserved.